Page 19 - Special Access Program News Today

19.11.2022 - VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the Company or Core One) is pleased to announce the initial production run of its psilocybin active pharmaceutical ... Seite 1

VANCOUVER, BC / ACCESSWIRE / November 18, 2022 / Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) (the "Company" or "Core One") is pleased to announce the initial production run

One of the easiest ways that governments can exert control over us is by withholding information from each and every one

In addition to providing new "tenets" for Space Force officials, "I'm really messaging three things to industry — that I really want them to give me credible proposals, and I really want them to execute, and I'm not going to tolerate poor performance," Frank Calvelli told Breaking Defense.

/PRNewswire/ - Apex Labs Ltd. ("APEX" or the "Company"), a pharmaceutical company optimizing the standard of mental health care for Veterans, is pleased to...

A Vancouver-based pharmaceutical company will run the first take-home psilocybin clinical trial in North America.

On September 1, 2022, a Panel of the Patented Medicine Prices Review Board (PMPRB) issued a decision that the price of Horizon Pharma’s PROCYSBI (cysteamine delayed release capsules)...

Earlier this month, Alberta announced new regulations for the use of psychedelics in therapy. Researchers and health-care professionals are increasingly exploring how drugs like ketamine can be used for mental health treatment.

While the National Defense Authorization Act (NDAA) defined “open systems” at a high-level, each branch of the U.S. military is determining what that means for them. Collins Aerospace Mosarc™ solutions can address that across next-gen systems like NGAD, FVL, and KC-X.

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has developed a tea bag containing psilocybin for use in clinical research and, if the...